BAE Systems plc (BSP)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 22.87 |
|---|---|
| 52-week range | 18.06 – 27.43 |
| Return, 1 month / 3 months | −3.3% / −0.6% |
| Return, 1 year / 3 years | +7.5% / +93.2% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 31.4% |
| Worst drawdown (1 year) | -22.3% |
| Average daily value traded | 1.30M EUR |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BAE Systems is a defence, security and aerospace company based in the United Kingdom. It designs and builds military aircraft, combat vehicles, warships and submarines, and supplies missiles, artillery and electronic systems. Its customers are chiefly governments and armed forces, particularly in the United Kingdom and the United States, and it also provides support and maintenance services for the equipment it supplies. The company operates through divisions covering air, maritime, land and cyber and intelligence activities.
On this site BAE Systems plc appears as a stock on the XETRA Stock Exchange (Germany), code BSP, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BAE Systems plc (BSP) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 22.87 on 23 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 253 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.5% and over the last three months it fell 0.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.5% | ||
| From 52-week high | -15.6% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.6% | ||
| 6-month return | -5.2% | ||
| 12-month return, skipping the last month | 11.2% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.3% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 1.30M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −3.3% |
| 3 months | −0.6% |
| 6 months | −5.2% |
| 1 year | +7.5% |
| 3 years | +93.2% |
| 5 years | +261.5% |
Signals
| 50-day / 200-day average | 23.26 / 23.45 |
|---|---|
| Golden / death cross (60 days) | Death, 2 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.54 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Apr 2026 | GBP 0.2703 |
| 23 Oct 2025 | GBP 0.1600 |
| 17 Apr 2025 | GBP 0.2442 |
| 24 Oct 2024 | GBP 0.1470 |
| 18 Apr 2024 | GBP 0.2193 |
| 19 Oct 2023 | GBP 0.1363 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.